Allogeneic nanostructured artificial human cornea
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Allogeneic nanostructured artificial human cornea, covering 2021-01-20 to 2021-01-20. Get the full timeline:
Most recent: Clinical Trial Update: Allogeneic Tissue Engineering (Nanostructured Artificial Human Cornea) in Patients With Corneal Trophic Ulcers in Advanced Stages, Refractory to Conventional (Ophthalmic) Treatment [Phase 1, Phase 2]